Trademark: 77754910
Word
NEUCARDIN
Status
Registered
Status Code
800
Status Date
Thursday, September 12, 2019
Serial Number
77754910
Registration Number
3734178
Registration Date
Tuesday, January 5, 2010
Mark Type
4000
Filing Date
Tuesday, June 9, 2009
Published for Opposition
Tuesday, October 20, 2009

Trademark Owner History
Zensun (Shanghai) Sci&Tech. Co., Ltd - Original Registrant

Classifications
5 (Based on Use in Commerce) Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Synthetic peptides for the treatment of cardiovascular disease (Based on 44(e) Biological preparations for medical purposes; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Synthetic peptides for the treatment of cardiovascular disease

Trademark Events
Sep 12, 2019
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Sep 12, 2019
Registered And Renewed (First Renewal - 10 Yrs)
Sep 12, 2019
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Sep 12, 2019
Case Assigned To Post Registration Paralegal
Sep 7, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 7, 2019
Teas Change Of Owner Address Received
Aug 29, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 29, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 31, 2019
Teas Change Of Correspondence Received
Jul 31, 2019
Teas Section 8 & 9 Received
Jan 5, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 5, 2019
Teas Change Of Owner Address Received
Jan 5, 2019
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 15, 2015
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Sep 15, 2015
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 14, 2015
Case Assigned To Post Registration Paralegal
Aug 12, 2015
Teas Section 8 & 15 Received
Jan 5, 2010
Registered-Principal Register
Nov 11, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 11, 2009
Teas Change Of Owner Address Received
Oct 20, 2009
Official Gazette Publication Confirmation E-Mailed
Oct 20, 2009
Published For Opposition
Sep 17, 2009
Law Office Publication Review Completed
Sep 17, 2009
Assigned To Lie
Sep 9, 2009
Approved For Pub - Principal Register
Sep 9, 2009
Assigned To Examiner
Jun 12, 2009
New Application Office Supplied Data Entered In Tram
Jun 12, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24